Cargando…
Screening breast cancer patients for Norwegian ATM mutations
Autores principales: | Laake, K, Vu, P, Andersen, TI, Erikstein, B, Kåresen, R, Lønning, PE, Skovlund, E, Børresen-Dale, A-L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300861/ http://dx.doi.org/10.1186/bcr163 |
Ejemplares similares
-
Screening breast cancer patients for Norwegian ATM mutations
por: Laake, K, et al.
Publicado: (2000) -
HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
por: Andersen, TI, et al.
Publicado: (2000) -
Genetic variants of CYP19 (aromatase) and breast cancer risk
por: Nedelcheva Kristensen, V, et al.
Publicado: (2000) -
Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000) -
Relation of gene expression-based tumor subclasses to clinical phenotypes
por: Sørlie, T, et al.
Publicado: (2000)